-
The new TrumpRx program relies partly on connecting consumers with discount coupons offered by drugmakers. For insured patients, though, using a coupon can prove dicey.
-
A bill that includes a stopgap measure to restore cuts to the AIDS Drug Assistance Program through June 30 — the end of the fiscal year — is heading to Gov. DeSantis' desk.
-
An amendment to a bill on drug costs adds $31 million to restore eligibility to people in the AIDS Drug Assistance Program, but the House hasn't decided whether to support the move.
-
The man, diagnosed with an autoimmune disorder, said he was reassured the drugmaker’s copay card would cover his share, but after two months, the card was empty.
-
The cuts to the AIDS Drug Assistance Program, which will reduce the income eligibility for aid and remove a key medication from coverage, are slated to take effect Saturday.
-
The measure, which must clear one more committee before going to the House floor, would begin what is described as a “most favored nation” system on drug prices in the state.
-
For decades, imported medicine has mostly been allowed to enter the U.S. duty free. Now, the president is threatening duties of 200% or more on foreign drugs.
-
Insurers will take drug costs, frequency of use and other factors into account as they set premium amounts for the 2026 plan year.
-
Young adults without jobs that provide insurance find their options are limited and expensive. The problem is about to get worse.
-
Criticism of prescription drug middlemen has intensified recently in the wake of a federal agency’s actions and legislative reform attempts.
-
President Joe Biden is campaigning on his efforts to cut drug costs for Medicare patients. But independent pharmacists say one strategy makes it unaffordable for them to keep some brand-name medicines in stock.
-
Independent pharmacists say they're losing money on many prescriptions they fill. “It’s just a lot of different elements in the system all at once," says a pharmacy assistant professor at FAMU.